Immunome, Inc.

NASDAQ:IMNM

12.54 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 165.332269.72398.67990.64138.41644.42420.32327.07834.64942.87949.22956.24359.82936.27639.7666.7449.789-2.5432.543-1.602
Short Term Investments 113.02139.98339.463000000000000005.08603.204
Cash and Short Term Investments 278.353309.706138.14290.64138.41644.42420.32327.07834.64942.87949.22956.24359.82936.27639.7666.7449.7892.5432.5431.602
Net Receivables 000.28900.2080.8210.8471.091.090.7954.3122.41.72.60.8500000
Inventory 0000-0.208-0.821-0.847000-4.3120-1.7-2.6-0.8500000
Other Current Assets 5.9313.626.2720.7731.112.1122.3261.0711.8592.6290.4924.9472.9864.8313.1280.7390.40200.5790
Total Current Assets 284.284313.326144.70391.41439.52646.53622.64929.23937.59846.30356.63861.1962.81541.10742.8947.48310.1912.5433.1221.602
Non-Current Assets:
Property, Plant & Equipment, Net 8.6195.763.6371.5171.3771.1460.9650.8750.9890.9430.8550.9611.2261.3861.5311.7411.79401.70
Goodwill 00000000000000000000
Intangible Assets 00000000000000000000
Goodwill and Intangible Assets 00000000000000000000
Long Term Investments 0.10.10.10.10.10.10.10.10.10.10.10.10.10.1000000
Tax Assets 00000000000000000000
Other Non-Current Assets 3.2120.5680.10.130.4320.3320.3320.3320.3320.3820.3320.307000.12.7590.229-2.5430.238-1.602
Total Non-Current Assets 11.9316.4283.8371.7471.9091.5781.3971.3071.4211.4251.2871.3681.3261.4861.6314.52.023-2.5431.938-1.602
Total Assets 296.215319.754148.5493.16141.43548.11424.04630.54639.01947.72857.92562.55864.14142.59344.52511.98312.21405.060
Liabilities & Equity:
Current Liabilities:
Account Payables 7.0477.1793.3112.7863.6993.312.43.1395.2593.893.0773.2771.792.9581.1872.6271.42200.5480
Short Term Debt 0.2950.4190.310.2490.4890.2360.2930.0910.0660.0610.3170.0160.0440.4440.4790.4490.42500.4510
Tax Payables 00000000000000000000
Deferred Revenue 12.58912.74510.49316.95617.66818.2150000-0.3174.37800000000
Other Current Liabilities 19.96910.4257.7153.124.5363.074.6384.1393.2935.7566.3340.0941.6871.1691.3722.330.94200.6660
Total Current Liabilities 39.930.76821.82923.11126.39224.8317.3317.3698.6189.7079.7287.7653.5214.5713.0385.4062.78901.6650
Non-Current Liabilities:
Long Term Debt 2.4771.2061.340.122000.0620.0930.1240.1470000.1340.1340.2110.32300.1130
Deferred Revenue Non-Current 02.2085.4892.8525.7059.42100000000000000
Deferred Tax Liabilities Non-Current 0-2.208-5.48900000000000000000
Other Non-Current Liabilities 02.2085.489610000000.01200.0030.0050.00855.4510.018038.9120
Total Non-Current Liabilities 2.4773.4146.82963.9745.7059.4210.0620.0930.1240.1470.01200.0030.1390.14255.6620.341039.0250
Total Liabilities 42.37734.18228.65887.08532.09734.2527.3937.4628.7429.8549.747.7653.5244.713.1861.0683.13040.690
Equity:
Preferred Stock 00000000000000055.4449.91338.89438.89427.513
Common Stock 0.0060.0060.0040.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.00100.001000
Retained Earnings -388.421-352.299-222.807-130.173-125.828-120.271-116.001-108.215-99.682-90.758-79.105-71.253-63.533-58.292-54.394-50.321-41.9440-36.5570
Accumulated Other Comprehensive Income/Loss 0.0020.0040.0220000000000000-1.841-35.63-1.519-25.205
Other Total Stockholders Equity 642.251637.861342.663136.248135.165134.132132.653131.298129.958128.631127.289126.045124.14996.17495.738-54.2042.9550-36.4480
Total Shareholders Equity 253.838285.572119.8826.0769.33813.86216.65323.08430.27737.87448.18554.79360.61737.88341.345-49.0859.0843.264-35.632.308
Total Equity 253.838285.572119.8826.0769.33813.86216.65323.08430.27737.87448.18554.79360.61737.88341.345-49.0859.0843.264-35.632.308
Total Liabilities & Shareholders Equity 296.215319.754148.5493.16141.43548.11424.04630.54639.01947.72857.92562.55864.14142.59344.52511.98312.2143.2645.062.308